High bone turnover is associated with low bone mass and spinal fracture in postmenopausal women

被引:56
|
作者
Ravn, P
Rix, M
Andreassen, H
Clemmesen, B
Bidstrup, M
Gunnes, M
机构
[1] ROSKILDE CTY HOSP KOGE,DEPT INTERNAL MED,ROSKILDE,DENMARK
[2] CTR CLIN OSTEOPOROSIS RES,HAUGESUND,NORWAY
关键词
tiludronate; postmenopausal osteoporosis; urinary CrossLaps; osteocalcin; bone mineral density; spinal fracture; osteoporosis;
D O I
10.1007/s002239900225
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A group of 366 healthy, white postmenopausal women, aged 50-81 years, mean age 66 years, were selected from the screened population of Scandinavians who were part of a multicenter study of the efficacy of tiludronate, a new bisphosphonate, in established postmenopausal osteoporosis, Eighty-eight women had a lumbar spine bone mineral density (BMD) above 0.860 g/cm(2), and 278 women had a BMD below 0.860 g/cm2. Spinal fracture was diagnosed from lateral spine X-ray studies and defined as at least 20% height reduction (wedge, compression, or endplate fracture) in at least one vertebra (T4-L4), Bone resorption was assessed by measurement of the urinary excretion of type I collagen degradation products by the CrossLapsTM enzyme-linked immunoassay (ELISA). Bone formation was assessed by ELISA measurement of the N-terminal-midfragment as well as the intact serum osteocalcin (OCN-MID), thus omitting the influence of the instability of osteocalcin caused by the labile 6 amino acid C-terminal sequence. The women were divided into groups with high or low bone turnover according to the concentrations of urinary CrossLapsTM or OCN-MID. Women in the quartiles with the highest concentrations of CrossLaps [519 +/- 119 mu g/mmol (SD)] or OCN-MID [44.6 +/- 7.5 ng/ml (SD)] had 10-16% lower spinal BMD compared with women in the lowest quartiles (CrossLaps 170 +/- 48 mu g/mmol (SD), and OCN-MID [22.1 +/- 3.0 ng/ml (SD)] (P < 0.0004). The prevalences of spinal fracture were 25 to 29% in the lowest quartiles, whereas the prevalences in the highest quartiles were almost double-53-54% (P < 0.006). If the women were subgrouped according to spinal BMD and prevalence of spinal fracture, corresponding results were found. Women with a BMD less than 0.860 g/cm(2), without or with spinal fracture (n = 136 and n = 142), had 36-43% higher concentration of CrossLaps (P = 0.0001) and 11-15% higher concentration of OCN-MID (P < 0.02), as compared with women with a BMD above 0.860 g/cm(2) and no spinal fracture (n = 84). In conclusion, the results indicate a strong association among high bone turnover, low bone mass, and prevalence of spinal fracture, which supports the theory that high bone turnover is a risk factor for spinal fracture and osteoporosis.
引用
收藏
页码:255 / 260
页数:6
相关论文
共 50 条
  • [1] HIGH BONE TURNOVER IS ASSOCIATED WITH LOW BONE MASS AND SPINAL FRACTURE IN POSTMENOPAUSAL WOMEN
    RAVN, P
    CLEMMESEN, B
    ANDREASSEN, H
    RIX, M
    GUNNES, M
    JOURNAL OF BONE AND MINERAL RESEARCH, 1995, 10 : S240 - S240
  • [2] High Bone Turnover is Associated with Low Bone Mass and Spinal Fracture in Postmenopausal Women
    P. Ravn
    M. Rix
    H. Andreassen
    B. Clemmesen
    M. Bidstrup
    M. Gunnes
    Calcified Tissue International, 1997, 60 : 255 - 260
  • [3] High bone turnover is associated with low bone mass in both pre- and postmenopausal women
    Ravn, P
    Fledelius, C
    Rosenquist, C
    Overgaard, K
    Christiansen, C
    BONE, 1996, 19 (03) : 291 - 298
  • [4] Low Bone Mass and High Bone Turnover in Postmenopausal Human Immunodeficiency Virus-Infected Women
    Yin, Michael T.
    McMahon, Don J.
    Ferris, David C.
    Zhang, Chiyuan A.
    Shu, Aimee
    Staron, Ronald
    Colon, Ivelisse
    Laurence, Jeffrey
    Dobkin, Jay F.
    Hammer, Scott M.
    Shane, Elizabeth
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (02): : 620 - 629
  • [5] EFFECTS OF IPRIFLAVONE ON BONE MASS AND BONE TURNOVER IN POSTMENOPAUSAL WOMEN WITH OSTEOPENIA
    AGNUSDEI, D
    BUFALINO, L
    GENNARI, C
    JOURNAL OF BONE AND MINERAL RESEARCH, 1993, 8 : S327 - S327
  • [6] Effects of low calcitonin doses on bone remodeling in postmenopausal women with high bone turnover rate
    Campusano, C
    López, JM
    Campino, C
    Cárdenas, I
    Rojas, A
    REVISTA MEDICA DE CHILE, 2000, 128 (04) : 387 - 391
  • [7] Denosumab effects on bone density and turnover in postmenopausal women with low bone mass with or without previous treatment
    Tsourdi, Elena
    Makras, Polyzois
    Rachner, Tilman D.
    Polyzos, Stergios
    Rauner, Martina
    Mandanas, Stylianos
    Hofbauer, Lorenz C.
    Anastasilakis, Athanasios D.
    BONE, 2019, 120 : 44 - 49
  • [8] Expression of microRNAs that regulate bone turnover in the serum of postmenopausal women with low bone mass and vertebral fractures
    Yavropoulou, Maria P.
    Anastasilakis, Athanasios D.
    Makras, Polyzois
    Tsalikakis, Dimitrios G.
    Grammatiki, Maria
    Yovos, John G.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2017, 176 (02) : 169 - 176
  • [9] Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass
    Bone, Henry G.
    Bolognese, Michael A.
    Yuen, Chui Kin
    Kendler, David L.
    Miller, Paul D.
    Yang, Yu-Ching
    Grazette, Luanda
    San Martin, Javier
    Gallagher, J. Christopher
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (04): : 972 - 980
  • [10] Effect of high dietary sodium on bone turnover markers and urinary calcium excretion in Korean postmenopausal women with low bone mass
    Park, S. M.
    Joung, J. Y.
    Cho, Y. Y.
    Sohn, S. Y.
    Hur, K. Y.
    Kim, J. H.
    Kim, S. W.
    Chung, J. H.
    Lee, M. K.
    Min, Y-K
    EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2015, 69 (03) : 361 - 366